Dr Lovly on the Investigation of BDTX-1535 in NSCLC onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
Further data from the pivotal Checkmate 816 trial continue to support the combination of nivolumab with chemotherapy in the neoadjuvant setting for patients with resectable non–small cell lung cancer.
Campaign aims to increase use of crucial biomarker testing in NSCLC healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
LUNGevity Foundation Amplifies Efforts to Improve Lung Cancer Patient Access to Comprehensive Biomarker Testing through New Awareness Campaign
New campaign aims to ensure there is No One Missed in receiving comprehensive biomarker testing and a fully informed diagnosis for the appropriate treatment
News provided by
Share this article
Share this article
WASHINGTON, Feb. 18, 2021 /PRNewswire/ LUNGevity Foundation will be launching a new lung cancer campaign called
No One Missed, created to drive essential comprehensive biomarker testing in non-small cell lung cancer (NSCLC). Guideline-recommended comprehensive biomarker testing can reveal vital information to help identify the appropriate individualized treatment plan for each NSCLC patient.
LUNGevity Foundation Amplifies Efforts to Improve Lung Cancer Patient Access to Comprehensive Biomarker Testing through New Awareness Campaign prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.